[HTML][HTML] Feasibility and acceptability of a proposed pharmacy-based harm reduction intervention to reduce opioid overdose, HIV and hepatitis C
W Jayawardene, PharmNet Research Team - Research in Social and …, 2020 - Elsevier
Background Evidence-based harm reduction intervention components which might benefit
pharmacy patients have not been integrated and studied. Objective To investigate the …
pharmacy patients have not been integrated and studied. Objective To investigate the …
Feasibility and Acceptability of a Proposed Pharmacy-Based Harm Reduction Intervention to Reduce Opioid Overdose, HIV and Hepatitis C
B Meyerson, JD Agley, WP Jayawardene… - Research in Social and …, 2019 - iu.tind.io
Background Evidence-based harm reduction intervention components which might benefit
pharmacy patients have not been integrated and studied. Objective To investigate the …
pharmacy patients have not been integrated and studied. Objective To investigate the …
Feasibility and acceptability of a proposed pharmacy-based harm reduction intervention to reduce opioid overdose, HIV and hepatitis C
BE Meyerson, JD Agley… - … in Social and …, 2020 - digitalcommons.butler.edu
Background: Evidence-based harm reduction intervention components which might benefit
pharmacy patients have not been integrated and studied. Objective: To investigate the …
pharmacy patients have not been integrated and studied. Objective: To investigate the …
Feasibility and acceptability of a proposed pharmacy-based harm reduction intervention to reduce opioid overdose, HIV and hepatitis C
PharmNet Research Team - Research in Social and …, 2020 - scholars.uthscsa.edu
Background: Evidence-based harm reduction intervention components which might benefit
pharmacy patients have not been integrated and studied. Objective: To investigate the …
pharmacy patients have not been integrated and studied. Objective: To investigate the …
[PDF][PDF] Feasibility and acceptability of a proposed pharmacy-based harm reduction intervention to reduce opioid overdose, HIV and hepatitis C
BE Meyerson, JD Agley, WP Jayawardene, LA Eldridge… - 2020 - scholar.archive.org
Background: Evidence-based harm reduction intervention components which might benefit
pharmacy patients have not been integrated and studied. Objective: To investigate the …
pharmacy patients have not been integrated and studied. Objective: To investigate the …
Feasibility and acceptability of a proposed pharmacy-based harm reduction intervention to reduce opioid overdose, HIV and hepatitis C.
BE Meyerson, JD Agley, W Jayawardene… - Research in Social & …, 2019 - europepmc.org
Background Evidence-based harm reduction intervention components which might benefit
pharmacy patients have not been integrated and studied. Objective To investigate the …
pharmacy patients have not been integrated and studied. Objective To investigate the …
Feasibility and acceptability of a proposed pharmacy-based harm reduction intervention to reduce opioid overdose, HIV and hepatitis C
BE Meyerson, JD Agley, W Jayawardene, LA Eldridge… - 2020 - repository.arizona.edu
Background: Evidence-based harm reduction intervention components which might benefit
pharmacy patients have not been integrated and studied. Objective: To investigate the …
pharmacy patients have not been integrated and studied. Objective: To investigate the …
[PDF][PDF] Feasibility and acceptability of a proposed pharmacy-based harm reduction intervention to reduce opioid overdose, HIV and hepatitis C
BE Meyerson, JD Agley, W Jayawardene… - Research in Social …, 2020 - addictions.iu.edu
Background: Evidence-based harm reduction intervention components which might benefit
pharmacy patients have not been integrated and studied. Objective: To investigate the …
pharmacy patients have not been integrated and studied. Objective: To investigate the …
[PDF][PDF] Feasibility and acceptability of a proposed pharmacy-based harm reduction intervention to reduce opioid overdose, HIV and hepatitis C
BE Meyerson, JD Agley, W Jayawardene… - Research in Social …, 2020 - academia.edu
Background: Evidence-based harm reduction intervention components which might benefit
pharmacy patients have not been integrated and studied. Objective: To investigate the …
pharmacy patients have not been integrated and studied. Objective: To investigate the …
Feasibility and acceptability of a proposed pharmacy-based harm reduction intervention to reduce opioid overdose, HIV and hepatitis C
BE Meyerson, JD Agley… - Research in social …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Evidence-based harm reduction intervention components which might benefit
pharmacy patients have not been integrated and studied. Objective To investigate the …
pharmacy patients have not been integrated and studied. Objective To investigate the …